To date, more than 400 types of human papillomavirus (HPV) have been identified. Despite
the creation of effective prophylactic vaccines against the most common genital HPVs, the …

Intralesional therapies are used for recalcitrant warts, but no Food and Drug Administration
(FDA) approved treatment exists nor is there consensus regarding the most efficacious …

Introduction Warts can be resistant to treatment or recur despite the use of various
destructive and immunotherapeutic modalities. Combination immunotherapy might …

Molluscum contagiosum (MC) is a skin and mucous membrane infection caused by the
molluscum virus (MCV). To evaluate safety and efficacy of intralesional injection of …

Background Immunostimulatory and antiproliferative therapies have been widely used for
the treatment of multiple warts. Recently, anti‐HPV activity of ionic contra viral therapy (ICVT) …

Recent studies that examined the treatment efficacy of Candida antigen injection for both
non-genital and genital warts yield inconsistent results. To address this, a systematic review …

Introduction Warts, benign skin growths caused by various human papillomavirus strains,
are categorized as genital and non-genital. Non-genital warts often lack noticeable …

Abstract Design Interventional, prospective, four arm randomized control. Setting Outpatient
department, Department of Dermatology, Venereology and Leprology, AIIMS Jodhpur …

BackgroundWarts are benign epidermal proliferations caused by the human papillomavirus.
The current therapies are either destructive, leading to scar formation, or less effective …

WART THERAPY WITH INTRALESIONAL MEASLES, MUMPS, AND RUBELLA
VACCINATION Page 1 NEUROQUANTOLOGY | March 2023 | Volume 21 | Issue 5|Page …